Genetics

Identification of mutations predisposing to thrombosis in the patient's genetic material. The test includes identification of mutations in the Factor V (F5) gene, mutations in the Prothrombin (F2) gene, and polymorphisms in the MTHFR gene.

Identification of MTHFR Gene Polymorphism in the Patient's Genetic Material

Identification of mutations in the Prothrombin (F2) gene in the patient's genetic material.

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection with high-risk human papillomavirus (HPV).

The HPV and CINtec Plus test enables the detection of neoplastic changes at the cellular stage, which are in the very early stages of development. This allows for the localization of cells where the normal cycle has been disrupted due to infection by high-risk human papillomavirus (HPV).

Identification of mutations in the Factor V (F5) gene in the patient's genetic material, commonly known as the Leiden V mutation.

Test Package Consisting of: CINtec PLUS p16/Ki67, Liquid-Based Cytology (LBC), HPV14.

Test Package Consisting of: CINtec PLUS p16/Ki67 – A test performed to deepen the diagnosis of precancerous changes and cervical cancer, Liquid-Based Cytology (LBC): A more modern and precise cytological examination technique, HPV14: Identification of 14 HPV genotypes (Human Papilloma Virus).

Molecular Testing (Real-Time PCR) is a highly sensitive and specific method that detects the genetic material (DNA) of the most commonly found human parasites, including.

The test involves analyzing stool for the presence of Cryptosporidium parvum DNA.